Martin obtained a PhD in Biochemistry from the University of Konstanz in a joint program with the University of Michigan. After postdoctoral training at the University of Washington, Martin joined Amunix Pharmaceuticals to work on long-acting protein therapeutics. In his current role at Roche, he serves as Head of Biochemical & Analytical Research, a department with 90+ scientists involved in protein characterization and assay development from lead selection to the start of clinical studies. Under his leadership, the department has advanced multiple next generation antibodies from research into early development. As a member of the Large Molecule Research leadership team, Martin is also responsible for the departments digital and automation strategy.